Form 6-K CHINA LIFE INSURANCE CO For: Nov 29

November 29, 2021 6:06 AM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Commission File Number 001-31914

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

November 29, 2021

 

 

China Life Insurance Company Limited

(Translation of registrant’s name into English)

 

 

16 Financial Street

Xicheng District

Beijing 100033, China

Tel: (86-10) 6363-3333

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes  ☐            No  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-  ☐

 

 

 


Commission File Number 001-31914

On November 29, 2021, China Life Insurance Company Limited issued an announcement in Chinese, the English translation of which is attached as Exhibit 99.1 hereto.

EXHIBIT LIST

 

Exhibit    Description
99.1    English translation of the announcement, dated November 29, 2021


Commission File Number 001-31914

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

           

China Life Insurance Company Limited

      (Registrant)
    By:  

/s/ Su Hengxuan

November 29, 2021    

Name:

Title:

 

(Signature)

Su Hengxuan

President and Executive Director

 

Exhibit 99.1

Commission File Number 001-31914

 

LOGO

中 國 人 壽 保 險 股 份 有 限 公 司

CHINA LIFE INSURANCE COMPANY LIMITED

(A joint stock limited company incorporated in the People’s Republic of China with limited liability)

(the “Company”)

(Stock Code: 2628)

CHINA LIFE INSURANCE COMPANY LIMITED

ANNOUNCEMENT ON THE PROGRESS OF CONNECTED TRANSACTION IN RELATION TO THE SUBSCRIPTION OF CAPITAL INCREASE OF CHINA GUANGFA BANK

At the thirty-sixth meeting of the sixth session of the Board of Directors (the “Board”) of China Life Insurance Company Limited (the “Company”), the Board reviewed and approved the proposed subscription by the Company for additional shares to be issued by China Guangfa Bank (“CGB”) (the “Transaction”). This Transaction constitutes a connected transaction of the Company. For detailed information, please refer to the Announcement on Connected Transaction of Proposed Subscription of Capital Increase of CGB filed by the Company on the website of Shanghai Stock Exchange (www.sse.com.cn) on May 27, 2021 (Lin 2021-025).

As of November 29, 2021, the Company has completed the execution of the Share Subscription Agreement (the “Agreement”) with CGB (the “Subscription”). To maintain the Company’s shareholding percentage in CGB, pursuant to the Agreement, the Company subscribed for 918,578,836 common shares of CGB with the par value of RMB 1.00 per share. The subscription price is RMB 8.7364 per share and RMB 8,025,072,142.83 in total.

Upon the completion of this Subscription, the Company will hold 9,519,210,262 shares of CGB and the shareholding percentage of the Company in CGB will remain to be 43.686%. This Subscription will not cause CGB to become a subsidiary of the Company or change the scope of the consolidated financial statements of the group (the Company and its subsidiaries).

The issuance of additional shares of CGB is subject to approvals by China Banking and Insurance Regulatory Commission, China Securities Regulatory Commission and other regulatory authorities. The final status of the Transaction is subject to these approvals by relevant regulatory authorities.

Board of Directors of China Life Insurance Company Limited

November 29, 2021



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings